Published in Circ J on November 01, 2002
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 5.00
Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci U S A (2005) 2.08
Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol (2003) 2.52
Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem (2002) 2.42
Electrophysiologic properties of pulmonary veins assessed using a multielectrode basket catheter. J Am Coll Cardiol (2004) 1.85
Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues. Arterioscler Thromb Vasc Biol (2006) 1.84
Reduction of P-wave duration and successful pulmonary vein isolation in patients with atrial fibrillation. J Cardiovasc Electrophysiol (2007) 1.82
Expression of human apoAII in transgenic rabbits leads to dyslipidemia: a new model for combined hyperlipidemia. Arterioscler Thromb Vasc Biol (2009) 1.64
Addition of a Nitric Oxide Donor to an Angiotensin II Type 1 Receptor Blocker May Cancel Its Blood Pressure-Lowering Effects. Int Heart J (2015) 1.54
Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan. Hypertens Res (2012) 1.51
Association between hypertension and coronary artery disease as assessed by coronary computed tomography. J Clin Hypertens (Greenwich) (2011) 1.49
Comparison of the efficacy and safety of statin and statin/ezetimibe therapy after coronary stent implantation in patients with stable angina. J Cardiol (2012) 1.48
Impact of glycemic control on the clinical outcome in diabetic patients with percutaneous coronary intervention--from the FU-registry. Circ J (2011) 1.45
A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study). Circ J (2010) 1.45
Lifestyle changes through the use of delivered meals and dietary counseling in a single-blind study. The STYLIST study. Circ J (2012) 1.44
Novel molecular imaging of atherosclerosis with gallium-68-labeled apolipoprotein A-I mimetic peptide and positron emission tomography. Circ J (2013) 1.43
Associations between metabolic factors and coronary plaque growth or arterial remodeling as assessed by intravascular ultrasound in patients with stable angina. Hypertens Res (2008) 1.42
Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation. EMBO Rep (2008) 1.40
The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res (2004) 1.40
Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor. J Biol Chem (2006) 1.38
Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis (2006) 1.33
Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents. J Clin Invest (2010) 1.26
Molecular analysis of the structure and function of the angiotensin II type 1 receptor. Hypertens Res (2003) 1.15
Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state. Mol Endocrinol (2007) 1.12
Coronary-pulmonary artery fistula with anomalous vessels arising from the right coronary sinus detected by 64-MDCT. Intern Med (2009) 1.11
High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol (2003) 1.09
Review: angiotensin II type 1 receptor blockers: class effects versus molecular effects. J Renin Angiotensin Aldosterone Syst (2010) 1.08
Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. J Biol Chem (2005) 1.07
Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol (2007) 1.06
Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model. J Cardiovasc Electrophysiol (2003) 1.04
A small difference in the molecular structure of angiotensin II receptor blockers induces AT₁ receptor-dependent and -independent beneficial effects. Hypertens Res (2010) 1.03
Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry). Am J Cardiol (2010) 1.00
Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Hypertension (2003) 1.00
Activation of extracellular signal-activated kinase by angiotensin II-induced Gq-independent epidermal growth factor receptor transactivation. Hypertens Res (2004) 0.98
Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats. J Am Coll Cardiol (2008) 0.93
Clinical significance of flow-mediated dilation, brachial intima-media thickness and pulse wave velocity in patients with and without coronary artery disease. Circ J (2012) 0.93
CXCR3 chemokine receptor-plasma IP10 interaction in patients with coronary artery disease. Circ J (2003) 0.92
Association between coronary artery calcification score as assessed by multi-detector row computed tomography and upstroke time of pulse wave. Intern Med (2007) 0.92
Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins. Atherosclerosis (2005) 0.91
Calcification of the medial layer of the internal thoracic artery in diabetic patients: relevance of glycoxidation. J Vasc Res (2003) 0.91
Splicing variant of Cdc42 interacting protein-4 disrupts beta-catenin-mediated cell-cell adhesion: expression and function in renal cell carcinoma. Biochem Biophys Res Commun (2005) 0.90
Statins induce the regression of left ventricular mass in patients with angina. Circ J (2004) 0.90
Do valsartan and losartan have the same effects in the treatment of coronary artery disease? Circ J (2007) 0.90
Ezetimibe, a selective inhibitor of the transport of cholesterol. Intern Med (2008) 0.90
Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2007) 0.89
Chymase inhibitor improves survival in hamsters with myocardial infarction. J Cardiovasc Pharmacol (2003) 0.89
Reperfusion-induced arrhythmias are suppressed by inhibition of the angiotensin II type 1 receptor. Cardiology (2003) 0.89
Left ventricular pseudoaneurysm following acute myocardial infarction. Intern Med (2006) 0.89
Reconstituted high-density lipoprotein attenuates postinfarction left ventricular remodeling in rats. Atherosclerosis (2008) 0.88
Nifedipine-induced vascular endothelial growth factor secretion from coronary smooth muscle cells promotes endothelial tube formation via the kinase insert domain-containing receptor/fetal liver kinase-1/NO pathway. Hypertens Res (2005) 0.88
Pilsicainide for atrial fibrillation. Drugs (2006) 0.88
Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockers. Curr Pharm Des (2013) 0.87
Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration. Atherosclerosis (2005) 0.87
Low-density lipoprotein oxidized to various degrees activates ERK1/2 through Lox-1. Atherosclerosis (2005) 0.87
Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. Atherosclerosis (2006) 0.87
Dominant-negative lox-1 blocks homodimerization of wild-type lox-1-induced cell proliferation through extracellular signal regulated kinase 1/2 activation. Hypertension (2006) 0.87
Comparison of the efficacy and safety of single-pill fixed-dose combinations of losartan/hydrochlorothiazide and valsartan/hydrochlorothiazide in patients with hypertension (SALT-VAT study). Intern Med (2011) 0.87
Diagnostic evaluation of acute pancreatitis in two patients with hypertriglyceridemia. World J Gastroenterol (2004) 0.87
Isolated pulmonary arterial stenosis caused by Takayasu's arteritis in an elderly male. J Cardiol (2008) 0.86
Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population. Circ J (2007) 0.86
Venous thrombosis associated with a large uterine myoma. Intern Med (2008) 0.86
Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin. Coron Artery Dis (2012) 0.85
Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation. Hypertens Res (2009) 0.85
Multivalent ligand-receptor interactions elicit inverse agonist activity of AT(1) receptor blockers against stretch-induced AT(1) receptor activation. Hypertens Res (2009) 0.85
Spontaneous onset of ventricular fibrillation in Brugada syndrome with J wave and ST-segment elevation in the inferior leads. Heart Rhythm (2005) 0.85
Genotypic Effect of ABCG1 gene promoter -257T>G polymorphism on coronary artery disease severity in Japanese men. J Atheroscler Thromb (2009) 0.84
In vitro transfer of antisense oligodeoxynucleotides into coronary endothelial cells by ultrasound. Biochem Biophys Res Commun (2002) 0.84
Long-term effects of box isolation on sympathovagal balance in atrial fibrillation. Circ J (2010) 0.84
Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta. Cardiovasc Res (2002) 0.84
Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation. Circ J (2007) 0.84
Effects of statin and lipoprotein metabolism in heart failure. J Cardiol (2010) 0.84
Impact of cigarette smoking cessation on high-density lipoprotein functionality. Circ J (2014) 0.84
Clinical significance of the coronary calcification score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients. Circ J (2006) 0.84
Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an old molecule. J Atheroscler Thromb (2011) 0.83
Usefulness of the evaluation of stent fracture by 64-multi-detector row computed tomography. J Cardiol (2008) 0.83
Efficacy and safety of a single-pill fixed-dose combination of high-dose telmisartan/hydrochlorothiazide in patients with uncontrolled hypertension. J Renin Angiotensin Aldosterone Syst (2012) 0.83
Reactivity of direct assays for low-density lipoprotein (LDL) cholesterol toward charge-modified LDL in hypercholesterolemia. Circ J (2012) 0.83
Is chronic kidney disease associated with coronary artery stenosis or calcification as assessed by multi-detector row computed tomography? Intern Med (2008) 0.83
Molecular mechanisms of the antagonistic action between AT1 and AT2 receptors. Biochem Biophys Res Commun (2009) 0.83
Carcinosarcoma-induced endothelial cells tube formation through KDR/Flk-1 is blocked by TNP-470. Cancer Lett (2004) 0.82
ATP-binding cassette transporter G4 is highly expressed in microglia in Alzheimer's brain. Brain Res (2008) 0.82
Small molecules with similar structures exhibit agonist, neutral antagonist or inverse agonist activity toward angiotensin II type 1 receptor. PLoS One (2012) 0.82
Comparison of the efficacy and safety of irbesartan and olmesartan in patients with hypertension (EARTH study). Clin Exp Hypertens (2012) 0.82
Increased carotid artery plaque score is an independent predictor of the presence and severity of coronary artery disease. J Cardiol (2008) 0.82
Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits. Arterioscler Thromb Vasc Biol (2004) 0.82
Comparison of the efficacies of irbesartan and olmesartan after successful coronary stent implantation. Intern Med (2013) 0.82
Non-ACE pathway-induced angiotensin II production. Curr Pharm Des (2013) 0.82
Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits. Atherosclerosis (2011) 0.82
Acute coronary syndrome associated with essential thrombocythemia. J Cardiol (2009) 0.82
New approach to pulmonary vein isolation for atrial fibrillation using a multielectrode basket catheter. Circ J (2006) 0.82
Human chymase expression in a mice induces mild hypertension with left ventricular hypertrophy. Hypertens Res (2003) 0.81
Association between the angiotensin I-converting enzyme gene insertion/deletion polymorphism and endurance running speed in Japanese runners. J Physiol Sci (2010) 0.81
Inhibition of cholesteryl ester transfer protein increases serum apolipoprotein (apo) A-I levels by increasing the synthesis of apo A-I in rabbits. Atherosclerosis (2004) 0.81
Randomized, double-blind, controlled, comparative trial of formula food containing soy protein vs. milk protein in visceral fat obesity. -FLAVO study-. Circ J (2011) 0.81
POPC/apoA-I discs as a potent lipoprotein modulator in Tangier disease. Atherosclerosis (2007) 0.81
Ras/Raf1-dependent signal in sphingosine-1-phosphate-induced tube formation in human coronary artery endothelial cells. Biochem Biophys Res Commun (2003) 0.81
HDL-associated factors provide additional prognostic information for coronary artery disease as determined by multi-detector row computed tomography. Int J Cardiol (2009) 0.81
Chymase inhibitors. Curr Pharm Des (2013) 0.80
JTT-705 blocks cell proliferation and angiogenesis through p38 kinase/p27(kip1) and Ras/p21(waf1) pathways. Atherosclerosis (2005) 0.80
Significance of urinary liver-fatty acid-binding protein in cardiac catheterization in patients with coronary artery disease. Intern Med (2009) 0.80